Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články
PubMed
1699493
DOI
10.1016/0166-3542(90)90014-x
PII: 0166-3542(90)90014-X
Knihovny.cz E-zdroje
- MeSH
- adenin analogy a deriváty chemická syntéza farmakologie MeSH
- adenosin analogy a deriváty farmakologie MeSH
- antivirové látky * chemická syntéza farmakologie MeSH
- cidofovir MeSH
- cytosin analogy a deriváty chemická syntéza farmakologie MeSH
- DNA viry účinky léků enzymologie MeSH
- guanin analogy a deriváty chemická syntéza farmakologie MeSH
- inhibitory reverzní transkriptasy MeSH
- inhibitory syntézy nukleových kyselin MeSH
- nukleotidy chemická syntéza farmakologie MeSH
- organofosfonáty * MeSH
- organofosforové sloučeniny chemická syntéza farmakologie MeSH
- purinnukleosidfosforylasa metabolismus MeSH
- ribonukleotidreduktasy metabolismus MeSH
- techniky in vitro MeSH
- tubercidin farmakologie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- 2-aminoadenosine MeSH Prohlížeč
- 3-deazaadenosine MeSH Prohlížeč
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine MeSH Prohlížeč
- 9-(3-hydroxy-2-phosphonomethoxypropyl)guanine MeSH Prohlížeč
- 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine MeSH Prohlížeč
- adefovir MeSH Prohlížeč
- adenin MeSH
- adenosin MeSH
- antivirové látky * MeSH
- cidofovir MeSH
- cytosin MeSH
- guanin MeSH
- inhibitory reverzní transkriptasy MeSH
- inhibitory syntézy nukleových kyselin MeSH
- nukleotidy MeSH
- organofosfonáty * MeSH
- organofosforové sloučeniny MeSH
- purinnukleosidfosforylasa MeSH
- ribonukleotidreduktasy MeSH
- tubercidin MeSH
Several N-(S)-(3-hydroxy-2-phosphonylmethoxypropyl) (HPMP) and N-(2-phosphonylmethoxyethyl) (PME) derivatives of purine bases (adenine, guanine, 2-aminoadenine, 3-deazaadenine) and cytosine inhibit the growth of various DNA viruses. PME-derivatives (PMEA, PMEG and PMEDAP) are also active against retroviruses. Both types of nucleotide analogues undergo phosphorylation by cellular nucleotide kinases to their mono- and diphosphates. The phosphorylation with crude extracts of L-1210 cells is potentiated by an ATP-regenerating system. HPMPA is phosphorylated faster than PMEA with or without the ATP-regenerating system. The HPMP and PME analogues inhibit several virus-encoded target enzymes and their cellular counterparts: (1) HSV-1 DNA polymerase is inhibited by the diphosphates of the PME series; the virus-encoded enzyme is more sensitive than HeLa DNA pol alpha and beta. PMEApp terminates the growing DNA chain; it specifically replaces dATP. HPMPApp also acts as an alternative substrate of dATP, but, in contrast with PMEApp, it permits limited chain growth. (2) Diphosphates of both series inhibit HSV-1 ribonucleotide reductase; the greatest inhibition of CDP reduction to dCDP is exhibited by HPMPApp and PMEApp. The enzyme isolated from a PMEA-resistant HSV-1 mutant proved less sensitive to PMEApp, hydroxyurea and HPMPApp. (3) Diphosphates of PME derivatives efficiently inhibit AMV(MAV) reverse transcriptase. (4) The purine HPMP and PME analogues and, even more so, their monophosphate derivatives inhibit purine nucleoside phosphorylase from L-1210 cells.
Citace poskytuje Crossref.org